Dr. Meyer has disclosed that he has received research support from Peregrine Pharmaceuticals and DFIN, Inc. The remaining authors have disclosed that they have no financial interests, arrangements, affiliations, or commercial interests with the manufacturers of any products discussed in this article or their competitors.
See JNCCN.org for supplemental online content.
JohnsonLGMadeleineMMNewcomerLM. Anal cancer incidence and survival: the Surveillance, Epidemiology, and End Results experience, 1973-2000. Cancer2004;101:281–288.
WilkinsonJRMorrisEJDowningA. The rising incidence of anal cancer in England 1990-2010: a population-based study. Colorectal Dis2014;16:O234–239.
KlasJVRothenbergerDAWongWDMadoffRD. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer1999;85:1686–1693.
ShridharRShibataDChanEThomasCR. Anal cancer: current standards in care and recent changes in practice. CA Cancer J Clin2015;65:139–162.
DalyBOlopadeOI. A perfect storm: how tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin2015;65:221–238.
CarethersJM. Screening for colorectal cancer in African Americans: determinants and rationale for an earlier age to commence screening. Dig Dis Sci2015;60:711–721.
O'KeefeEBMeltzerJPBetheaTN. Health disparities and cancer: racial disparities in cancer mortality in the United States, 2000-2010. Front Public Health2015;3:51.
AlamriYBuchwaldPDixonL. Salvage surgery in patients with recurrent or residual squamous cell carcinoma of the anus. Eur J Surg Oncol2016;42:1687–1692.
BenjaminsMRHuntBRRaleighSM. Racial disparities in prostate cancer mortality in the 50 largest US cities. Cancer Epidemiol2016;44:125–131.
AkinyemijuTMooreJXOjesinaAI. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socioeconomic status and healthcare resources. Breast Cancer Res Treat2016;157:575–586.
BergerMDYangDSunakawaY. Impact of sex, age, and ethnicity/race on the survival of patients with rectal cancer in the United States from 1988 to 2012. Oncotarget2016;7:53668–53678.
KimHWKimJHLimBJ. Sex disparity in gastric cancer: female sex is a poor prognostic factor for advanced gastric cancer. Ann Surg Oncol2016;23:4344–4351.
BristowREChangJZiogasA. Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status. Gynecol Oncol2014;134:60–67.
ChangEHLutfiWFeinglassJ. National trends in the surgical treatment of non-advanced medullary thyroid cancer (MTC): an evaluation of adherence with the 2009 American Thyroid Association guidelines. World J Surg2016;40:2930–2940.
Dell'OglioPAbou-HaidarHLeyh-BannurahSR. Assessment of the rate of adherence to international guidelines for androgen deprivation therapy with external-beam radiation therapy: a population-based study. Eur Urol2016;70:429–435.
ArmstrongKMcMurphySDeanLT. Differences in the patterns of health care system distrust between blacks and whites. J Gen Intern Med2008;23:827–833.
LaVeistTANickersonKJBowieJV. Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients. Med Care Res Rev2000;57(Suppl 1):146–161.
BittermanDSGrewDGuP. Comparison of anal cancer outcomes in public and private hospital patients treated at a single radiation oncology center. J Gastrointest Oncol2015;6:524–533.
ChiaoEYGiordanoTPRichardsonPEl-SeragHB. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era. J Clin Oncol2008;26:474–479.
Crum-CianfloneNFHullsiekKHMarconiVC. Anal cancers among HIV-infected persons: HAART is not slowing rising incidence. AIDS2010;24:535–543.
ShielsMSPfeifferRMChaturvediAK. Impact of the HIV epidemic on the incidence rates of anal cancer in the United States. J Natl Cancer Inst2012;104:1591–1598.
AlbertsCJvan RooijenMSPrinsM. HIV is an important risk factor for human papillomavirus types 16 and 18 seropositivity among sexually active men who have sex with men. Sex Transm Dis2015;42:129–134.
AbioyeAISoipeAISalakoAA. Are there differences in disease progression and mortality among male and female HIV patients on antiretroviral therapy? A meta-analysis of observational cohorts. AIDS Care2015;27:1468–1486.
JarrinIGeskusRBhaskaranK. Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women. Am J Epidemiol2008;168:532–540.
NakamuraHAndoKShinmyoT. Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysis. Ann Thorac Cardiovasc Surg2011;17:469–480.
FakhryCWestraWHWangSJ. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Cancer2017;123:1566–1575.
Osazuwa-PetersNMassaSTChristopherKM. Race and sex disparities in long-term survival of oral and oropharyngeal cancer in the United States. J Cancer Res Clin Oncol2016;142:521–528.
HleyhelMBelotABouvierAM. Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort. Int J Cancer2015;137:2443–2453.
HammadNHeilbrunLKGuptaS. Squamous cell cancer of the anal canal in HIV-infected patients receiving highly active antiretroviral therapy: a single institution experience. Am J Clin Oncol2011;34:135–139.
Marin-MullerCLiMChenCYaoQ. Current understanding and potential immunotherapy for HIV-associated squamous cell carcinoma of the anus (SCCA). World J Surg2009;33:653–660.
SimoniJMHuhDWilsonIB. Racial/Ethnic disparities in ART adherence in the United States: findings from the MACH14 study. J Acquir Immune Defic Syndr2012;60:466–472.
KongMCNahataMCLacombeVA. Association between race, depression, and antiretroviral therapy adherence in a low-income population with HIV infection. J Gen Intern Med2012;27:1159–1164.
LeydenWAManosMMGeigerAM. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst2005;97:675–683.
TaplinSHIchikawaLYoodMU. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?J Natl Cancer Inst2004;96:1518–1527.